Portal de Periódicos da CAPES

MAGE, BAGE and GAGE genes experiences in fresh epithelial ovarian carcinomas

1996; Wiley; Volume: 67; Issue: 3 Linguagem: Inglês

10.1002/(sici)1097-0215(19960729)67

1097-0215

Vincenzo Russo, Piero Dalerba, Axel Ricci, Cristina Bonazzi, Biagio Eugenio Leone, Costantino Mangioni, Paola Allavena, Claudio Bordignon, Catia Traversari,

Cancer Immunotherapy and Biomarkers

International Journal of CancerVolume 67, Issue 3 p. 457-460 Letter to the EditorFree Access MAGE, BAGE and GAGE genes experiences in fresh epithelial ovarian carcinomas Vincenzo Russo, Vincenzo Russo Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorPiero Dalerba, Piero Dalerba Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorAxel Ricci, Axel Ricci Dipartimento di Patologia, Università di Milan, Milan, ItalySearch for more papers by this authorCristina Bonazzi, Cristina Bonazzi Istituto Mario Negri, Milan, ItalySearch for more papers by this authorB. E. Leone, B. E. Leone Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorCostantino Mangioni, Costantino Mangioni Istituto Mario Negri, Milan, ItalySearch for more papers by this authorPaola Allavena, Paola Allavena II Divisione Chirurgia Generale, Istituto Scientifico H.S. Raffaele, Milan, ItalySearch for more papers by this authorClaudio Bordignon, Claudio Bordignon Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorCatia Traversari, Corresponding Author Catia Traversari Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalyGene Therapy Program, DIBIT, Istituto Scientifico H.S. Raffaele, Via Olgettina 58, 20132 Milano, Italy. FAX: 02 26434827Search for more papers by this author Vincenzo Russo, Vincenzo Russo Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorPiero Dalerba, Piero Dalerba Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorAxel Ricci, Axel Ricci Dipartimento di Patologia, Università di Milan, Milan, ItalySearch for more papers by this authorCristina Bonazzi, Cristina Bonazzi Istituto Mario Negri, Milan, ItalySearch for more papers by this authorB. E. Leone, B. E. Leone Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorCostantino Mangioni, Costantino Mangioni Istituto Mario Negri, Milan, ItalySearch for more papers by this authorPaola Allavena, Paola Allavena II Divisione Chirurgia Generale, Istituto Scientifico H.S. Raffaele, Milan, ItalySearch for more papers by this authorClaudio Bordignon, Claudio Bordignon Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalySearch for more papers by this authorCatia Traversari, Corresponding Author Catia Traversari Gene Therapy Program, Dipartimento di Biologia e Biotecnologia (DIBIT), Università di Milan, Milan, ItalyGene Therapy Program, DIBIT, Istituto Scientifico H.S. Raffaele, Via Olgettina 58, 20132 Milano, Italy. FAX: 02 26434827Search for more papers by this author First published: 29 July 1996 https://doi.org/10.1002/(SICI)1097-0215(19960729)67:3 3.0.CO;2-3Citations: 25AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Allavena, P., Lo Presti, P., di Bello, M., Lucchini, V., Lissoni, A., Zanetta, G., Mangioni, C. and Mantovani, A., Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells. Cancer Immunol. Immunother., 27, 69–76 (1988). Boel, P., Wildmann, C., Sensi, M.-L., Brasseur, F., Renauld, J.-C., Coulie, P., Boon, T. and van der Bruggen, P., BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167–175 (1995). Boon, T., Gajewski, T. F. and Coulie, P., From defined human tumor antigens to effective immunization? Immunol. Today, 16, 334–336 (1995). Fisk, B., Blevins, T. L., Wharton, J. T. and Ioannides, C. G., Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocytes lines. J. exp. Med., 181, 2109–2117 (1995). Gaugler, B., van den Eynde, B., van der Bruggen, P., Pedro, R., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F. and Boon, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921–930 (1994). Ioannides, C. G., Fisk, B., Pollack, M. S., Frazier, M. L., Wharton, J. T. and Freedman, R. S., Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognized common determinants on non ovarian tumor clones. Scand. J. Immunol., 37, 413–424 (1993). Patard, J-J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., Francoise, P., Abi-Aad, A., van Cangh, P., Abbuo, C. C., Chopin, D. and Boon, T., Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer, 64, 60–64 (1995). Peoples, G. E., Goedegebuure, P. S., Smith, R., Linehan, D. C., Yoshino, I. and Eberlein, T. J., Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc. nat. Acad. Sci. (Wash.), 92, 432–436 (1995). Russo, V., Traversari, C., Verrecchia, A., Mottolese, M., Natali, P. G. and Bordignon, C., Expression of the MAGE gene family in primary and metastatic human breast cancer. Implications for tumor antigen-specific immunotherapy. Int. J. Cancer, 64, 216–221 (1995). van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S. and Boon, T., A new family of genes coding for an antigen recognized by autologous cytolytic lymphocytes on a human melanoma. J. exp. Med., 182, 689–698 (1995). van der Bruggen, P., Szikora, J-P., Boel, P., Weldmann, C., Somville, M., Sensi, M. and Boon, T., Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanoma expressing HLA-Cw* 1601. Europ. J. Immunol., 9, 2134–2140 (1994). Weynants, P., Lethé B., Brasseur, F., Marchand, M. and Boon, T., Expression of MAGE genes by non-small cell lung carcinomas. Int. J. Cancer, 56, 826–829 (1994). Citing Literature Volume67, Issue329 July 1996Pages 457-460 ReferencesRelatedInformation